176 related articles for article (PubMed ID: 25294916)
1. Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment.
Jiang S; Pogue BW; Kaufman PA; Gui J; Jermyn M; Frazee TE; Poplack SP; DiFlorio-Alexander R; Wells WA; Paulsen KD
Clin Cancer Res; 2014 Dec; 20(23):6006-15. PubMed ID: 25294916
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes.
Jiang S; Pogue BW; Carpenter CM; Poplack SP; Wells WA; Kogel CA; Forero JA; Muffly LS; Schwartz GN; Paulsen KD; Kaufman PA
Radiology; 2009 Aug; 252(2):551-60. PubMed ID: 19508985
[TBL] [Abstract][Full Text] [Related]
3. Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography.
Zhu Q; Ademuyiwa FO; Young C; Appleton C; Covington MF; Ma C; Sanati S; Hagemann IS; Mostafa A; Uddin KMS; Grigsby I; Frith AE; Hernandez-Aya LF; Poplack SS
Breast Cancer Res Treat; 2021 Aug; 188(3):615-630. PubMed ID: 33970392
[TBL] [Abstract][Full Text] [Related]
4. Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.
Tran WT; Gangeh MJ; Sannachi L; Chin L; Watkins E; Bruni SG; Rastegar RF; Curpen B; Trudeau M; Gandhi S; Yaffe M; Slodkowska E; Childs C; Sadeghi-Naini A; Czarnota GJ
Br J Cancer; 2017 May; 116(10):1329-1339. PubMed ID: 28419079
[TBL] [Abstract][Full Text] [Related]
5. Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
Deng B; Muldoon A; Cormier J; Mercaldo ND; Niehoff E; Moffett N; Saksena MA; Isakoff SJ; Carp SA
J Biomed Opt; 2024 Jun; 29(6):066001. PubMed ID: 38737790
[TBL] [Abstract][Full Text] [Related]
6. Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography.
Altoe ML; Kalinsky K; Marone A; Kim HK; Guo H; Hibshoosh H; Tejada M; Crew KD; Accordino MK; Trivedi MS; Hershman DL; Hielscher AH
Breast Cancer Res; 2021 Jan; 23(1):16. PubMed ID: 33517909
[TBL] [Abstract][Full Text] [Related]
7. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
Schaafsma BE; van de Giessen M; Charehbili A; Smit VT; Kroep JR; Lelieveldt BP; Liefers GJ; Chan A; Löwik CW; Dijkstra J; van de Velde CJ; Wasser MN; Vahrmeijer AL
Clin Cancer Res; 2015 Feb; 21(3):577-84. PubMed ID: 25473002
[TBL] [Abstract][Full Text] [Related]
8. Changes in Diffuse Optical Tomography Images During Early Stages of Neoadjuvant Chemotherapy Correlate with Tumor Response in Different Breast Cancer Subtypes.
Altoe ML; Kalinsky K; Marone A; Kim HK; Guo H; Hibshoosh H; Tejada M; Crew KD; Accordino MK; Trivedi MS; Hershman DL; Hielscher AH
Clin Cancer Res; 2021 Apr; 27(7):1949-1957. PubMed ID: 33451976
[TBL] [Abstract][Full Text] [Related]
9. Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment.
Cochran JM; Busch DR; Leproux A; Zhang Z; O'Sullivan TD; Cerussi AE; Carpenter PM; Mehta RS; Roblyer D; Yang W; Paulsen KD; Pogue B; Jiang S; Kaufman PA; Chung SH; Schnall M; Snyder BS; Hylton N; Carp SA; Isakoff SJ; Mankoff D; Tromberg BJ; Yodh AG
J Biomed Opt; 2018 Oct; 24(2):1-11. PubMed ID: 30338678
[TBL] [Abstract][Full Text] [Related]
10. Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients.
Lim EA; Gunther JE; Kim HK; Flexman M; Hibshoosh H; Crew K; Taback B; Campbell J; Kalinsky K; Hielscher A; Hershman DL
Breast Cancer Res Treat; 2017 Apr; 162(3):533-540. PubMed ID: 28190249
[TBL] [Abstract][Full Text] [Related]
11. Early detection of chemotherapy-refractory patients by monitoring textural alterations in diffuse optical spectroscopic images.
Sadeghi-Naini A; Vorauer E; Chin L; Falou O; Tran WT; Wright FC; Gandhi S; Yaffe MJ; Czarnota GJ
Med Phys; 2015 Nov; 42(11):6130-46. PubMed ID: 26520706
[TBL] [Abstract][Full Text] [Related]
12. Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.
Ueda S; Roblyer D; Cerussi A; Durkin A; Leproux A; Santoro Y; Xu S; O'Sullivan TD; Hsiang D; Mehta R; Butler J; Tromberg BJ
Cancer Res; 2012 Sep; 72(17):4318-28. PubMed ID: 22777823
[TBL] [Abstract][Full Text] [Related]
13. Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer.
Cao X; Muller KE; Chamberlin MD; Gui J; Kaufman PA; Schwartz GN; diFlorio-Alexander RM; Pogue BW; Paulsen KD; Jiang S
Clin Cancer Res; 2023 Dec; 29(23):4822-4829. PubMed ID: 37733788
[TBL] [Abstract][Full Text] [Related]
14. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.
Baek HM; Chen JH; Nie K; Yu HJ; Bahri S; Mehta RS; Nalcioglu O; Su MY
Radiology; 2009 Jun; 251(3):653-62. PubMed ID: 19276320
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?
Pakalniskis MG; Wells WA; Schwab MC; Froehlich HM; Jiang S; Li Z; Tosteson TD; Poplack SP; Kaufman PA; Pogue BW; Paulsen KD
Radiology; 2011 May; 259(2):365-74. PubMed ID: 21406632
[TBL] [Abstract][Full Text] [Related]
16. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
[TBL] [Abstract][Full Text] [Related]
17. Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer.
Yu YH; Zhu X; Mo QG; Cui Y
Clin Transl Oncol; 2018 Apr; 20(4):524-533. PubMed ID: 28921461
[TBL] [Abstract][Full Text] [Related]
18. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
19. MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer.
Cattell RF; Kang JJ; Ren T; Huang PB; Muttreja A; Dacosta S; Li H; Baer L; Clouston S; Palermo R; Fisher P; Bernstein C; Cohen JA; Duong TQ
Clin Breast Cancer; 2020 Feb; 20(1):68-79.e1. PubMed ID: 31327729
[TBL] [Abstract][Full Text] [Related]
20. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
